METHOD AND SYSTEM TO DISPLAY ANALYTE SENSOR DATA

• US 20130137952A1
• Filed: 03/23/2011
• Published: 05/30/2013
• Est. Priority Date: 03/31/2010
• Status: Abandoned Application

• Current Assignee: LifeScan IP Holdings, LLC
• Original Assignee: Animas Corporation (Johnson & Johnson)
• Inventors: McLaughlin, Brian, McCann, Thomas, Keller, Eric, Fuhs, Thomas, Walton, David, Porter, John
• Application Number:
  US13/637,277
• Publication Number:
  US 20130137952A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 2560/045 with a separable interface unit, e.g. for communication
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/743 Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

Described and illustrated herein are an exemplary methods and system to display analyte sensor data. Such method may be achieved by the medical device receiving data from the analyte sensor for a period of time and displaying a target zone and a graphical representation of the data in which one or more portions of the graphical representation comprises a specific indicia of clinical risk.

Claims

1. A method of monitoring analyte concentrations of a user over time, the method comprising:

determining with an analyte sensor that transforms signals of analyte concentrations in physiological fluid of the user over a period of time into determined analyte concentration data; and

displaying a target zone of upper and lower analyte concentration thresholds, a first indicia representative of the determined analyte concentration data in the target zone, and a second indicia representative of the determined analyte concentration data outside of the target zone.

2. The method of claim 1, in which the displaying further comprises displaying a third indicia for at least one analyte concentration of the determined analyte concentration data below the target zone.

3. The method of claim 1, in which the target zone comprises a threshold value indicative of clinical risks arising from diabetes.

4. The method of claim 2, in which each of the first, second and third indices comprises respective symbols.

5. The method of claim 2, in which each of the indices further comprises a color.

6. The method of claim 1, in which each of the indices comprises an icon.

7. The method of claim 1, in which the analyte sensor comprises a continuous glucose sensor.

8. The method of claim 1, in which the displaying comprises displaying a trend indicative symbol to represent a trend of determined analyte concentration data over a predetermined time frame.

9. A system for diabetes management, the system comprising:

an analyte sensor configured to transmit data transformed from a user'"'"'s signals representing analyte concentrations over time;

an infusion pump including a microprocessor configured to receive data from the analyte sensor; and

a display connected to the microprocessor that exhibits a target zone of upper and lower analyte concentration thresholds, a first indicia representative of the determined analyte concentration data in the target zone, and a second indicia representative of determined analyte concentration data outside of the target zone.

10. The system of claim 9, in which each of the indices comprises a color.

11. The system of claim 9, in which each of the indices comprises a symbol.

12. The system of claim 9, in which each of the indices comprises an icon.

13. The system of claim 9, in which the display comprises an OLED disposed in a housing of the infusion pump.

14. The system of claim 9, in which the display comprises a display configured to exhibit a trend indicative symbol to represent a trend of the determined analyte concentration over a predetermined time frame.

15. A system for processing and displaying data from an analyte sensor, the system comprising:

an analyte sensor that transforms analyte measurements conducted by the analyte sensor into signals representative of the analyte measurements;

a handheld portable microprocessor device configured to receive signals from the analyte sensor, the handheld portable device including a screen that displays a target zone of upper and lower analyte concentration thresholds, a first indicia representative of the determined analyte concentration data in the target zone, and a second indicia representative of the determined analyte concentration data outside of the target zone.

16. The system of claim 15, in which each of the first and second indicia comprises a color.

17. The system of claim 15, in which each of the first and second indicia comprises a symbol.

18. The system of claim 15, in which each of the first and second indicia comprises an icon.

19. The system of claim 15, in which the analyte sensor comprises a continuous glucose sensor.

20. A method of monitoring analyte concentrations of a user over time, the method comprising:

receiving data from a sensor that transforms signals representative of analyte concentrations in a physiological fluid of the user over a period of time; and

displaying a target zone of upper and lower analyte concentration thresholds, a first indicia representative of the data representative of analyte concentrations in the target zone, and a second indicia representative of the received data representative of analyte concentrations outside of the target zone.

21. The method of claim 20, in which the displaying further comprises displaying a third indicia for at least one analyte concentration below the target zone.

22. The method of claim 20, in which the target zone comprises a threshold value indicative of clinical risks arising from diabetes.

23. The method of claim 21, in which each of the first, second and third indices comprises respective symbols.

24. The method of claim 21, in which each of the indices further comprises a color.

25. The method of claim 20, in which each of the indices comprises an icon.